Global Preclinical Imaging (In-VIVO) Market – Forecasts to 2026

The data examined by GME predicted that by 2026, the Global Preclinical Imaging (In-Vivo) Market would grow with a CAGR value of 6.2 percent. Preclinical imaging in vivo is market expected to develop at a rapid pace in the near future, due to factors such as the technology advances and a rise in the incidence of chronic diseases like rheumatoid arthritis, neurological diseases, cancer, and cardiovascular disease.

Browse the Report @ https://www.globalmarketestimates.com/market-report/global-preclinical-imaging-in-vivo-market-3208

By Modality (Optical Imaging, PET, SPECT, CT, MRI, Ultrasound, Photoacoustic Imaging, Magnetic Particle Imaging), By Reagent (Optical Imaging Reagents, Contrast Agents, PET Tracers, SPECT Probes), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis
Key Market Insights
• For drug creation, preclinical imaging (In-Vivo) is used in live animal testing. Preclinical imaging is also used to track patient reactions and look for early signs of efficacy.
• Micro Ultrasound played a major role in 2020 and is expected to rise at the highest rate, owing to its wide variety of applications and effectiveness in conducting research on small animal models.
• The preclinical optical imaging reagents bagged the top market share during the period of 2021 to 2026.
• FUJIFILM Holdings Corporation, MR Solutions Ltd., Bruker Corporation, Trifoil Imaging, Mediso Ltd, Aspect Imaging, LI-COR Biosciences, MILabs B.V., PerkinElmer, Inc., and Miltenyi Biotec GmbH are some major players competing in the global preclinical imaging market.

Browse the Report @ https://www.globalmarketestimates.com/market-report/global-preclinical-imaging-in-vivo-market-3208

Modality Outlook (Revenue, USD Million, 2021-2026)
• Optical Imaging Systems
• Bioluminescence/Fluorescence Imaging Systems
• Standalone Fluorescence Imaging Systems
• Optical + X-Ray/Optical + CT
• Preclinical Nuclear Imaging Systems
• Micro-PET Systems
• Micro-SPECT Systems
• Trimodality (SPECT/PET/CT) Systems
• Micro-MRI Systems
• Micro-Ultrasound Systems
• Micro-CT Systems
• Preclinical Photoacoustic Imaging Systems
• Preclinical Magnetic Particle Imaging (MPI) Systems

Reagent Outlook (Revenue, USD Million, 2021-2026)
• Preclinical Optical Imaging Reagents
• Bioluminescent Imaging Reagents
• Fluorescent Imaging Reagents
• Preclinical Nuclear Imaging Reagents
• Preclinical PET Tracers
• Preclinical SPECT Probes
• Preclinical MRI Contrast Agents
• Gadolinium-based Preclinical MRI Contrast Agents
• Iron-based Preclinical MRI Contrast Agents
• Manganese-based Preclinical MRI Contrast Agents
• Preclinical Ultrasound Contrast Agents
• Preclinical CT Contrast Agents
• Iodine-based Preclinical CT Contrast Agents
• Barium-based Preclinical CT Contrast Agents
• Gold Nanoparticles
• Gastrografin-based Preclinical CT Contrast Agents

Regional Outlook (Revenue, USD Million, 2021-2026)
North America
• The U.S.
• Canada
• Mexico
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Rest of APAC
Central & South America
• Brazil
• Argentina
• Rest of CSA
Middle East & Africa
• Saudi Arabia
• UAE
• Rest of MEA

Contact: Yash Jain
Email address: yash.jain@globalmarketestimates.com
Phone Number: +16026667238
Website: https://www.globalmarketestimates.com/
Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php

B-502, Kemp Plaza, Mindspace, Malad West, Mumbai: 400 064, India

Global Market Estimates is an India based market research and consulting company. The company provides syndicated research reports, customised research reports and consulting services to their clients and helps them achieve their business goals on a commercial level. Global Market Estimates database is used by the world's well known and prolific academic institutions and Fortune 500 companies to understand the global and regional business environment to excel in their business goals.

This release was published on openPR.